Tag: CPAP Therapy
DMEs improve adherence, lower costs & reduce utilization, study finds
March 25, 2025HME News Staff
DALLAS – There are significant advantages for patients receiving continuous glucose monitors through DME providers compared to pharmacies, including higher adherence rates, according to a new study published in Clinical Diabetes, a peer-reviewed journal of the American Diabetes Association.
The study, supported by CCS, demonstrates that efforts to expand access to CGMs by adding pharmacy as a new channel for distribution — alongside the established DME provider channel —...
Sleep apnea patients on CPAP therapy live longer, study finds
March 19, 2025HME News Staff
SAN DIEGO – CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea, according to a landmark meta-analysis supported by Resmed and published in The Lancet Respiratory Medicine.
The study, which analyzed data from more than 1 million sleep apnea patients worldwide across 30 studies, found those on CPAP therapy have:
A 37% lower risk of dying from any cause compared to those with OSA who do not use CPAP.
A 55% lower risk of dying...
Lofta, PMTA partner for trucking safety
February 24, 2025HME News Staff
SAN DIEGO – Lofta has announced a strategic partnership with the Pennsylvania Motor Truck Association to increase access to streamlined at-home sleep apnea testing and treatment for trucking professionals. Through the partnership, PMTA members will benefit from Lofta Direct’s comprehensive at-home sleep apnea program, which provides fast, accurate diagnoses without the need to visit an overnight lab. Lofta will also provide ongoing CPAP therapy support for diagnosed drivers and ensure...
Sleep race
October 25, 2024Liz Beaulieu, Editor
Just as we were putting the final touches on the October issue, Apple announced that its new smartwatch would include a sleep apnea feature.
We were expecting this. Earlier this year, Samsung Electronics announced that the sleep apnea feature on the Samsung Health Monitor app had received de novo authorization from the U.S. Food and Drug Administration, and everyone expected that Apple and Google were not far behind.
Following Samsung’s announcement, a consistent topic of...
Eli Lilly says tirzepatide reduces OSA severity
June 24, 2024HME News Staff
INDIANAPOLIS – Eli Lilly’s tirzepatide demonstrated a mean reduction of up to 62.8% on the apnea-hypopnea index (AHI), or about 30 fewer events restricting or blocking a person's airflow per hour of sleep, compared to placebo, according to the company’s SURMOUNT-OSA phase 3 clinical trials evaluating the drug for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity, with and without CPAP therapy.
In a key secondary endpoint, the company...
EnsoData, Aeroflow partner to increase adherence
May 21, 2024HME News Staff
MADISON, Wis., and ASHEVILLE, N.C. – EnsoData and Aeroflow Health have announced a strategic partnership to use predictive clinical AI tools to enable more timely patient care, increase patient adherence and strengthen the provider-patient connection.
As part of the partnership, Aeroflow’s sleep coaches will use EnsoTherapy to provide rapid, personalized support to patients who are struggling with therapy adherence. EnsoTherapy’s task generation and smart-prioritization allow...
Researchers use grant to ID risk for cardiovascular disease in OSA patients
March 12, 2024HME News Staff
NEW YORK – Mount Sinai researchers have received a $3 million grant from the National Institutes of Health to develop and study AI-powered models to identify the risk of cardiovascular disease events in patients with obstructive sleep apnea. Researchers will use machine-learning techniques on comprehensive multi-modal datasets to identify patients at enhanced risk for buildup of fats and cholesterol in the artery walls, and heightened risk for cardiovascular events such as heart attack and...
EnsoData, React Health partner
October 30, 2023HME News Staff
MADISON, Wis., and SARASOTA, Fla. – EnsoData has partnered with React Health to optimize CPAP adherence support for patients with sleep apnea. As part of the partnership, EnsoData’s adherence prediction AI technology will be integrated into React Health’s recently launched Connect patient management software platform, empowering physicians and HME providers with actionable data to provide timely, personalized support to patients who are struggling with therapy. “By partnering...
sovaSage integrates with React Health
October 30, 2023HME News Staff
PITTSBURGH – sovaSage has completed an integration with React Health’s Connect patient management software platform. Earlier this year, sovaSage introduced Jeanie, an AI-based CPAP coach technology, to manage the initial 90-day compliance period and long-term compliance and support. “React Health has made significant inroads in the sleep therapy market and has established itself as a strong provider of sleep products and technology,” said William Kaigler, founder and CEO of...
sovaSage's Jeanie grants ‘strategic advantage’
June 2, 2023Liz Beaulieu, Editor
PITTSBURGH – sovaSage is in a “huge growth cycle,” with a new product for patients on CPAP therapy called TherapistAssist Jeanie and a number of key hires, says William Kaigler, co-founder.
The company had a soft launch for Jeanie, an artificial intelligence-based virtual coach that delivers customized written and video-based content to patients 24/7/365, at Medtrade in March.
“There’s nothing else like it,” said Kaigler, who previously founded...